Can a Century-Old vaccine stop bladder Cancer's return?
NCT ID NCT06747455
Summary
This study is testing whether a treatment called BCG, given directly into the bladder, can prevent early-stage bladder cancer from coming back after tumor removal surgery. It will involve 438 adults who have had surgery for intermediate or high-risk non-muscle-invasive bladder cancer. The main goal is to see if BCG treatment improves the one-year and two-year rates of staying cancer-free compared to standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BCG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, China
Contact
Conditions
Explore the condition pages connected to this study.